114 related articles for article (PubMed ID: 2403366)
41. [Synthesis of N-(4-substituted amino-4-oxobutyryl)-N-substituted glycines].
Wu Y; Cai CY; Gong KS
Yao Xue Xue Bao; 1992; 27(9):717-20. PubMed ID: 1293947
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of angiotensin converting enzyme by aldehyde and ketone substrate analogues.
Grobelny D; Galardy RE
Biochemistry; 1986 Mar; 25(5):1072-8. PubMed ID: 3008817
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and angiotensin converting enzyme-inhibitory activity of N-[(1S)-1-carboxy-5-(4-piperidyl)pentyl]-L-alanine derivatives.
Kori M; Itoh K; Inada Y; Katoh T; Sumino Y; Nishikawa K; Sugihara H
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):580-5. PubMed ID: 8004703
[TBL] [Abstract][Full Text] [Related]
44. The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex.
Barnes NM; Costall B; Egli P; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ
Brain Res Bull; 1990 Jul; 25(1):183-5. PubMed ID: 2207707
[TBL] [Abstract][Full Text] [Related]
45. Kinetics of slow, tight-binding inhibitors of angiotensin converting enzyme.
Goli UB; Galardy RE
Biochemistry; 1986 Nov; 25(22):7136-42. PubMed ID: 3026447
[TBL] [Abstract][Full Text] [Related]
46. N-protected tripeptide inhibitors of angiotensin converting enzyme.
Kayahara H; Ohashi A; Tadasa K; Kato S
Agric Biol Chem; 1990 May; 54(5):1325-6. PubMed ID: 1368622
[No Abstract] [Full Text] [Related]
47. Design of conformationally constrained angiotensin-converting enzyme inhibitors.
Weller HN; Gordon EM; Rom MB; Pluscec J
Biochem Biophys Res Commun; 1984 Nov; 125(1):82-9. PubMed ID: 6095846
[TBL] [Abstract][Full Text] [Related]
48. Inhibitors of angiotensin-converting enzyme containing a tetrahedral arsenic atom.
Galardy RE; Kortylewicz ZP
Biochem J; 1985 Mar; 226(2):447-54. PubMed ID: 2986596
[TBL] [Abstract][Full Text] [Related]
49. Specificity of the Escherichia coli proline transport system.
Rowland I; Tristram H
J Bacteriol; 1975 Sep; 123(3):871-7. PubMed ID: 1099081
[TBL] [Abstract][Full Text] [Related]
50. Inactivation of angiotensin converting enzyme by sodium nitroprusside.
Park JW; Means GE
Biochem Biophys Res Commun; 1987 Jun; 145(3):1048-53. PubMed ID: 3038088
[TBL] [Abstract][Full Text] [Related]
51. Crystallographic studies of angiotensin converting enzyme inhibitors and analysis of preferred zinc coordination geometry.
Hausin RJ; Codding PW
J Med Chem; 1990 Jul; 33(7):1940-7. PubMed ID: 2362274
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of human converting enzyme in vitro by a novel tripeptide analog.
Weare JA; Stewart TA; Gafford JT; Erdös EG
Hypertension; 1981; 3(3 Pt 2):I50-3. PubMed ID: 6266959
[TBL] [Abstract][Full Text] [Related]
53. Phosphorus-containing inhibitors of angiotensin-converting enzyme.
Thorsett ED; Harris EE; Peterson ER; Greenlee WJ; Patchett AA; Ulm EH; Vassil TC
Proc Natl Acad Sci U S A; 1982 Apr; 79(7):2176-80. PubMed ID: 6285369
[TBL] [Abstract][Full Text] [Related]
54. [Synthesis and analysis of conformationally restricted analogs of peptide inhibitors of the angiotensin-converting enzyme].
Filatova MP; Krit NA; Komarova OM; Orekhovich VN; Reissmann S
Bioorg Khim; 1986 Jan; 12(1):59-70. PubMed ID: 3004512
[TBL] [Abstract][Full Text] [Related]
55. Properties, metabolisms, and applications of (L)-proline analogues.
Bach TM; Takagi H
Appl Microbiol Biotechnol; 2013 Aug; 97(15):6623-34. PubMed ID: 23780584
[TBL] [Abstract][Full Text] [Related]
56. Muraceins--muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors. II. Isolation and structure determination.
Singh PD; Johnson JH
J Antibiot (Tokyo); 1984 Apr; 37(4):336-43. PubMed ID: 6327591
[TBL] [Abstract][Full Text] [Related]
57. Phosphonamidate and phosphothioate dipeptides as potential inhibitors of VanX.
Yang KW; Brandt JJ; Chatwood LL; Crowder MW
Bioorg Med Chem Lett; 2000 May; 10(10):1085-7. PubMed ID: 10843223
[TBL] [Abstract][Full Text] [Related]
58. Crystal structures of the even and odd bolaform amino acid derivatives (11-N-[benzyloxycarbonyl-L-alanyl]aminoundecanoyl)-L-alanyl benzyl ester and (12-N-[benzyloxycarbonyl-L-alanyl]aminododecanoyl)-L-alanyl benzyl ester.
Schade B; Hubert V; André C; Luger P; Fuhrhop JH
J Pept Res; 1997 Apr; 49(4):363-8. PubMed ID: 9176821
[TBL] [Abstract][Full Text] [Related]
59. Dipeptide-hydroxamates are good inhibitors of the angiotensin I-converting enzyme.
Harris RB; Strong PD; Wilson IB
Biochem Biophys Res Commun; 1983 Oct; 116(2):394-9. PubMed ID: 6316952
[TBL] [Abstract][Full Text] [Related]
60. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors.
Moore VA; Irwin WJ; Timmins P; Lambert PA; Chong S; Dando SA; Morrison RA
Int J Pharm; 2000 Dec; 210(1-2):29-44. PubMed ID: 11163985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
